|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev, Yu.Yu. Vinnik
An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia
|
№6 / 2021
|
|
O.I. Bratchikov, S.O. Artishchev, I.A. Tyuzikov
Vitamin D deficiency, metabolic syndrome, and prostate adenoma: current epidemiological trends and pathophysiological mechanisms of interaction
|
№4 / 2018
|
|
A.B. Zhiborev, A.G. Martov
The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia
|
№4 / 2018
|
|
R.G. Biktimirov, A.G. Martov, T.R. Biktimirov, A.A. Kaputovskii
The role of extraperitoneoscopic adenomectomy in the management of benign prostatic hyperplasia greater than 80 cm3
|
№6 / 2017
|
|
Yu.G. Alyaev, A.M. Pshikhachev, A.N. Perekalina
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
|
№5 / 2016
|
|
O.I. Apolikhin, A.V. Sivkov, E.K. Yanenko, M.I. Katibov, O.V. Zolotukhin, I.A. Shaderkin, M.Yu. Prosyannikov, D.A. Voitko, A.A. Tsoi,N. A. Galiev, Yu. V. Kastrikin
The incidence of acute urinary retention as an indicator of the quality of care for patients with benign prostatic hyperplasia
|
№2 / 2016
|
|
L.G. Spivak, K.L. Lokshin, A.Z. Vinarov
Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and α1-Blockers in Patients with Benign Prostatic Hyperplasia
|
№4 / 2015
|
|
N.F. Sergienko, M.I. Vasil'chenko, O.I. Kudrjashov, O.I. Bratchikov, A.I. Begaev, S.P. Shershnev, O.L. Rejnjuk, M.M. Lotockij, D.A. Zelenin
Classical Radical Extraurethral Method of Adenomectomy – Beyond 30 Years
|
№4 / 2015
|
|
M.I. Davidov, K.L. Lokshin, I.S. Gorbunova
Incidence of acute urinary retention in patients with prostatic adenoma and 8-year long tamsulosin therapy
|
№2 / 2015
|
|
Yu.L. Demidko, M.A. Gazimiev, A.M. Bayduvaliev, E.L. Lachinov, V.S. Saenko
The use of vitaprost in the treatment of patients with prostate diseases
|
№1 / 2014
|
|
G.G. Krivoborodov
Lower urinary tract symptoms in men
|
№1 / 2014
|
|
Rasner P.I., Pushkar D.Yu.
The evaluation of efficacy and safety of treatment with dalfaz SR in patients with prostatic adenoma
|
№3 / 2013
|
Русский
